引用本文:邓 鑫,梁 健,黄 彬,李益忠,覃黎葵,张锡流.天然牛磺酸对肝纤维化大鼠TGF-β1/Smad信号通路的影响[J].大连医科大学学报,2007,29(4):336-339.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
天然牛磺酸对肝纤维化大鼠TGF-β1/Smad信号通路的影响
邓 鑫1, 梁 健1, 黄 彬1, 李益忠1, 覃黎葵1, 张锡流2
1.广西中医学院 附属瑞康医院 肝胆内科, 广西 南宁 530011;2.广西中医学院 第一附属医院 病理科,广西 南宁 530023
摘要:
[目的]探讨天然牛磺酸对肝纤维化大鼠TGF-β1/Smad信号通路的影响。[方法]Wistar大鼠随机分成对照组、模型组、天然牛磺酸治疗组,采用CCL4诱导肝纤维化模型。酶联免疫吸附法(ELISA)测定血清TGF-β1含量;免疫组织化学法检测肝组织TGF-β1、Smad3、Smad7蛋白表达;RT-PCR检测肝组织TGF-β1、TβRI和TβRIImRNA表达;分别用HE染色和Masson染色。肝组织观察病理组织变化。[结果] 治疗组血清TGF-β1含量为(1.65±0.32)μg/L,显著低于模型组(3.93±0.32)μg/L,P<0.01;治疗组肝组织TGF-β1,Smad3蛋白表达分别为(4.5±0.6)%、(2.5±0.8)%,显著低于模型组(7.5±1.2)%、(3.9±0.8)%,P<0.05,Smad7为(6.2±1.3)%,显著高于模型组(1.3±0.2)%,P<0.01;治疗组肝组织TGF-β1,TβRI和TβRIImRNA表达分别为0.83±0.21、0.45±0.16、0.63±0.15,显著低于模型组1.62±0.45、0.93±0.24、1.25±0.45,P<0.01;治疗组肝纤维化分期积分为2.07±0.31,显著低于模型组3.18±0.42,P<0.01。[结论]天然牛磺酸能抑制TGF-β1及其受体和Smad3的表达,上调Smad7的表达,具有抑制肝纤维化的作用。
关键词:  牛磺酸  肝纤维化  转化生长因子-β1  Smad
DOI:10.11724/jdmu.2007.04.03
分类号:
基金项目:
Effects of natural taurine on TGF-β1/Smad singaling pathway in rats of hepatic fibrosis
DENG Xin1, LIANG Jian1, HUANG Bin1, LI Yi-zhong1, QIN Li-kui1, ZHANG Xi-liu2
1.The Affiliated Ruikang Hospital of Guangxi Traditional Chinese Medical College,Nanning 530011,China;2.The First Affiliated Hospital of Guangxi Traditional Chinese Medical College,Nanning 530011,China
Abstract:
[Objective]To investigate the Effects of natural taurine on TGF-β1/Smad singaling pathway in rats of hepatic fibrosis. [Methods]Wistar rats were randomly divided into normal group, model group and natural taurine treatment group(each group,n=20),hepatic fibrosis model were induced by CCL4. The serum concentration of TGF-β1was assayed with ELISA.The protein expression of TGF-β1,Smad4,Smad7, with immunohis- stochemistry method.The gene expression of TGF-β1,TβRI and TβRII with PR-PCR method.Histopathological changes in rat’s liver tissue were detected with HE and Masson collagen staining.[Results]Treatment group of serum concentration of TGF-β1were (1.65±0.32)μg/L ,being lower than that in model group (3.93±0.32)μg/L,P<0.01,the protein expression of TGF-β1,Smad3 were (4.5±0.6)%, (2.5±0.8)% respectively, being lower than that in model group (7.5±1.2)%, (3.9±0.8)%,P<0.05, Smad7 were (6.2±1.3)%, being higher than that in model group (1.3±0.2)%,P<0.01, the gene expression of TGF-β1, TβRI , TβRII were 0.83±0.21, 0.45±0.16, 0.63±0.15 respectively,being lower than that in model group 1.62±0.45, 0.93±0.24, 1.25±0.45,P<0.01. Treatment group of hepatic fibrosis score were 2.07±0.31, being lower than that in model group 3.18±0.42,P<0.01.[Conclusions]Natural taurine can inhibit the expression TGF-β1and it’s receptor,and increase the expression Smad7 and can inhibit hepatic fibrosis.
Key words:  taurine  hepatic fibrosis  transforming growth factor-β1   Smad